Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Obermiller

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Molecular Medicine|March 11, 2011
Ovarian Cancer Gene Therapy with BRCA1-An OverviewP S Obermiller, J T Holt
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1992
Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or deathD S Ucker, J Meyers, P S Obermiller
Gynecologic Oncology|December 6, 2000
Preclinical studies of a new generation retroviral vector for ovarian cancer BRCA1 gene therapyD L Tait, P S Obermiller, J T Holt
Breast Cancer Research : BCR|March 16, 2001
Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategiesP S Obermiller, D L Tait, J T Holt
Nucleic Acids Research|September 11, 1990
Analysis of substrate specificity of the PaeR7 endonuclease: effect of base methylation on the kinetics of cleavageS S Ghosh, P S Obermiller, T J Kwoh, et al.
Hematology/Oncology Clinics of North America|July 31, 1998
Ovarian cancer gene therapyD L Tait, P S Obermiller, R A Jensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stabilityD L Tait, P S Obermiller, A R Hatmaker, et al.
Nature Genetics|April 1, 1995
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progressionM E Thompson, R A Jensen, P S Obermiller, et al.
Molecular and Cellular Biology|July 1, 1992
Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytesD S Ucker, P S Obermiller, W Eckhart, et al.
Nucleic Acids Research|December 23, 1988
Introduction and expression of the bacterial PaeR7 restriction endonuclease gene in mouse cells containing the PaeR7 methylaseT J Kwoh, P S Obermiller, A W McCue, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Molecular Medicine|March 11, 2011
Ovarian Cancer Gene Therapy with BRCA1-An OverviewP S Obermiller, J T Holt
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1992
Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or deathD S Ucker, J Meyers, P S Obermiller
Gynecologic Oncology|December 6, 2000
Preclinical studies of a new generation retroviral vector for ovarian cancer BRCA1 gene therapyD L Tait, P S Obermiller, J T Holt
Breast Cancer Research : BCR|March 16, 2001
Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategiesP S Obermiller, D L Tait, J T Holt
Nucleic Acids Research|September 11, 1990
Analysis of substrate specificity of the PaeR7 endonuclease: effect of base methylation on the kinetics of cleavageS S Ghosh, P S Obermiller, T J Kwoh, et al.
Hematology/Oncology Clinics of North America|July 31, 1998
Ovarian cancer gene therapyD L Tait, P S Obermiller, R A Jensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stabilityD L Tait, P S Obermiller, A R Hatmaker, et al.
Nature Genetics|April 1, 1995
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progressionM E Thompson, R A Jensen, P S Obermiller, et al.
Molecular and Cellular Biology|July 1, 1992
Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytesD S Ucker, P S Obermiller, W Eckhart, et al.
Nucleic Acids Research|December 23, 1988
Introduction and expression of the bacterial PaeR7 restriction endonuclease gene in mouse cells containing the PaeR7 methylaseT J Kwoh, P S Obermiller, A W McCue, et al.
Pageof 2